top of page
Saravir Biotech: Antibody Therapy for Measles
A unique antibody countermeasure to the ongoing dramatic rise in measles cases worldwide
Our goal is to provide a new tool for prevention or treatment of measles to children and adults with unique antibodies.
"Measles anywhere is a threat everywhere."
(CDC 2025)
Saravir’s Unique Antibodies Bind And Neutralize
Measles Virus
Saravir’s unique antibodies bind a part of the virus that prevents the virus from entering cells. Some of these antibodies neutralize the virus and are not the same antibodies generated by vaccination. These antibodies so far have not shown any predilection to resistance.
Fact Sheet
bottom of page